mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |